Jane Street’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.7M Sell
452,104
-458,633
-50% -$6.7M ﹤0.01% 3086
2025
Q4
$14.5M Buy
910,737
+233,484
+34% +$3.31M ﹤0.01% 1905
2025
Q3
$7.48M Buy
677,253
+210,626
+45% +$2.3M ﹤0.01% 2815
2025
Q2
$3.95M Buy
466,627
+154,071
+49% +$1.24M ﹤0.01% 3340
2025
Q1
$2.51M Buy
312,556
+89,911
+40% +$728K ﹤0.01% 4002
2024
Q4
$2M Sell
222,645
-241,356
-52% -$1.97M ﹤0.01% 4095
2024
Q3
$3.4M Buy
464,001
+216,773
+88% +$1.34M ﹤0.01% 3497
2024
Q2
$1.41M Buy
247,228
+137,412
+125% +$724K ﹤0.01% 5113
2024
Q1
$550K Sell
109,816
-472,671
-81% -$3.21M ﹤0.01% 6488
2023
Q4
$5.24M Buy
582,487
+283,030
+95% +$2.33M ﹤0.01% 2781
2023
Q3
$2.33M Sell
299,457
-70,302
-19% -$688K ﹤0.01% 3798
2023
Q2
$3.58M Buy
369,759
+3,333
+0.9% +$34.6K ﹤0.01% 3220
2023
Q1
$4.02M Buy
366,426
+232,868
+174% +$2.05M ﹤0.01% 2748
2022
Q4
$577K Sell
133,558
-272,433
-67% -$1.58M ﹤0.01% 5877
2022
Q3
$3.05M Sell
405,991
-183,105
-31% -$1.58M ﹤0.01% 3424
2022
Q2
$5.92M Buy
589,096
+250,115
+74% +$2.8M ﹤0.01% 2418
2022
Q1
$4.2M Sell
338,981
-148,886
-31% -$2.3M ﹤0.01% 3335
2021
Q4
$11.2M Buy
487,867
+136,431
+39% +$3.23M ﹤0.01% 1750
2021
Q3
$5.76M Buy
351,436
+71,466
+26% +$1.13M ﹤0.01% 2513
2021
Q2
$3.63M Buy
279,970
+249,859
+830% +$3.18M ﹤0.01% 3210
2021
Q1
$391K Sell
30,111
-220,972
-88% -$3.21M ﹤0.01% 7240
2020
Q4
$3.47M Buy
251,083
+103,090
+70% +$1.5M ﹤0.01% 2610
2020
Q3
$2.18M Buy
147,993
+40,817
+38% +$591K ﹤0.01% 2900
2020
Q2
$1.74M Buy
+107,176
New +$1.72M ﹤0.01% 3256
2020
Q1
Sell
-26,024
Closed -$459K 5275
2019
Q4
$527K Buy
+26,024
New +$240K ﹤0.01% 3624
2018
Q4
Sell
-27,358
Closed -$182K 4911
2018
Q3
$182K Buy
+27,358
New +$153K ﹤0.01% 4725
2017
Q4
Sell
-10,041
Closed -$63K 4542
2017
Q3
$63K Buy
+10,041
New +$63.3K ﹤0.01% 4320
2017
Q2
Sell
-21,113
Closed -$155K 4304
2017
Q1
$155K Buy
+21,113
New +$97.5K ﹤0.01% 3915

Other funds holding AUPH